Heart failure in acute myocardial infarction: A comparison between patients with or without heart failure criteria from the FAST-MI registry;Insuficiencia cardiaca en el infarto agudo de miocardio: comparación de pacientes con o sin criterios de insuficiencia cardiaca del registro FAST-MI

Revista Espanola de Cardiologia

Volumn 65, Issue 4, 2012, Pages 326-333

  Juillire, Yves ^a   Cambou, Jean P ^b   Bataille, Vincent ^c   Mulak, Genevive ^b   Galinier, Michel ^c   Gibelin, Pierre ^d   Benamer, Hakim ^e   Bouvaist, Hélne ^f   Méneveau, Nicolas ^g   Tabone, Xavier ^e   Simon, Tabassome ^h   Danchin, Nicolas ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Société Franaise de Cardiologie   (France)

^c CHU RANGUEIL   (France)

^d Centre Hospitalier Universitaire Pasteur   (France)

^e CENTRE HOSPITALIER   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Beta blockers; Heart failure; Myocardial infarction; Survival

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ARTICLE; CONGESTIVE HEART FAILURE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; REGISTER; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CARDIOVASCULAR AGENTS; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART FAILURE; HEART FUNCTION TESTS; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84858860609     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.10.027     Document Type: Article

References (34)

1. N. Freemantle, J. Cleland, P. Toung, J. Mason, and J. Harrison β blockade after myocardial infarction: systematic review and meta-regression analysis BMJ 318 1999 1730 1737
2. The CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
3. M. Gheorghiade, and S. Goldstein Beta-blockers in the post-myocardial infarction patient Circulation 106 2002 394 398
4. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert the US Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
5. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised study Lancet 353 1999 9 13
6. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
7. M. Packer, A.J.S. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi the Carvedilol Prospective Randomized Cumulative Survival Study Group Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
8. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) Eur Heart J 26 2005 1115 1140
9. N. Danchin, J.P. Cambou, G. Hanania, Z. Kadri, N. Genes, J.M. Lablanche the USIC 2000 Investigators Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry Am Heart J 150 2005 1147 1153
10. M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, A. Cohen-Solal en representación del Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology The Euro-Heart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474
11. F. Arós, A. Loma-Osorio, J. Vila, L. López-Bescós, J. Cuñat, and E. Rodríguez Efecto de la asociación de bloqueadores beta e inhibidores de la enzima de conversión en la supervivencia al año tras un infarto agudo de miocardio. Resultados del registro PRIAMHO II Rev Esp Cardiol 59 2006 313 320
12. F. Arós, M. Heras, J. Vila, H. Sanz, I. Ferreira-González, and G. Permanyer-Miralda Reducción de la mortalidad precoz y a 6 meses en pacientes con IAM en el periodo 1995-2005. Datos de los registros PRIAMHO I, II y MASCARA Rev Esp Cardiol 64 2011 972 980
13. J.P. Cambou, T. Simon, G. Mulak, V. Bataille, N. Danchin the FAST-MI Investigators The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics Arch Mal Coeur 100 2007 524 534
14. P.A. McKee, W.P. Castelli, P. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1448
15. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 24 2003 28 66
16. N. Danchin, L. Vaur, N. Gens, M. Renault, J. Ferrires, and S. Etienne Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results J Am Coll Cardiol 30 1997 1598 1605
17. P. Marques-Vidal, J.B. Ruidavets, J.P. Cambou, and J. Ferrires Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993 Heart 84 2000 171 175
18. G. Hanania, J.P. Cambou, P. Gueret, L. Vaur, D. Blanchard, J.M. Lablanche the USIC 2000 Investigators Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry Heart 90 2004 1404 1410
19. C.S. Fox, J.C. Evans, M.G. Larson, W.B. Kannel, and D. Levy Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999. The Framingham Heart Study Circulation 110 2004 522 527
20. J.P. Hellermann, T.Y. Goraya, S.J. Jacobsen, S.A. Weston, G.S. Reeder, and B.J. Gersh Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 157 2003 1101 1107
21. F. Najafi, A.J. Dobson, M. Hobbs, and K. Jamrozik Temporal trends in the frequency and longer-term outcome of heart failure complicating myocardial infarction Eur J Heart Fail 9 2007 879 885
22. F.A. Spencer, T.E. Meyer, R.J. Goldberg, J. Yarzebski, M. Hatton, and D. Lessard Twenty year trend (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective J Am Coll Cardiol 34 1999 1378 1387
23. U.C. Guidry, J.C. Evans, M.G. Larson, P.W. Wilson, J.M. Murabito, and D. Levy Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study Circulation 100 1999 2054 2059
24. A. Torabi, J.G.F. Cleland, N.K. Khan, P.H. Loh, A.L. Clark, and F. Alamgir The timing of development and subsequent clinical course of heart failure after a myocardial infarction Eur Heart J 29 2008 859 870
25. A. Aouba, F. Péquignot, A. Le Toullec, and E. Jougla Les causes médicales de décs en France en 2004 et leur évolution 1980-2004 BEH Them 35-36 2007 308 314
26. S.C. Gan, S.K. Beaver, P.M. Houck, M.S. MacLehose, H.W. Lawson, and L. Chan Treatment of acute myocardial infarction and 30-day mortality among women and men N Engl J Med 343 2000 8 15
27. K.A.A. Fox, S.G. Goodman, F.A. Anderson Jr., C.B. Granger, M. Moscucci, M.D. Flather en representación de GRACE Investigators From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1414 1424
28. A.H. Wu, L. Parsons, N.R. Every, and E.R. Bates Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 2002 1389 1394
29. P.G. Steg, O.H. Dabbous, L.J. Feldman, A. Cohen-Solal, M.C. Aumont, and J. López-Sendón Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 2004 494 499
30. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
31. C.L. Pashos, S.L. Normand, J.B. Garkinkle, J.P. Newhouse, A.M. Epstein, and B.J. McNeil Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992 J Am Coll Cardiol 23 1994 1023 1030
32. J. Abdulla, S. Barlera, R. Latini, S. Kjoller-Hansen, P. Sogaard, and E. Christensen A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction Eur J Heart Fail 9 2007 129 135
33. P. De Groote, R. Isnard, P. Assyag, P. Clerson, A. Ducardonnet, and M. Galinier Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey Eur J Heart Fail 9 2007 1205 1211
34. E. López-de-Sá, A. Martínez, M. Anguita, D. Dobarro, and M. Jiménez-Navarro Uso de antagonistas de los receptores de aldosterona tras el infarto de miocardio. Datos del registro REICIAM Rev Esp Cardiol 64 2011 981 987